Revenue
2021
2022
2023
2024
2025
2026
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue | £376.8M | £317.6M | £324.7M | £311.2M | £325.8M | £461.3M |
| Research & development | −£822,000 | £0 | −£13,000 | −£170,000 | — | — |
| Operating expenses | £288.7M | £250.1M | £254.9M | £233.5M | £188.3M | £184.0M |
| Operating income | £103.4M | £89.6M | £65.6M | £54.5M | £93.7M | £225.8M |
| Operating margin | 27.43% | 28.20% | 20.19% | 17.51% | 28.75% | 48.94% |
| EBITDA | £118.8M | £100.4M | £92.7M | £70.1M | — | — |
| EBITDA margin | 31.54% | 31.60% | 28.55% | 22.53% | — | — |
| Net income | £73.7M | £62.2M | £46.9M | £41.4M | £71.5M | £178.1M |
| Net profit margin | 19.57% | 19.58% | 14.44% | 13.32% | 21.94% | 38.61% |
| Basic EPSper basic share | £0.28 | £0.23 | £0.17 | £0.15 | £0.25 | £0.62 |
| Diluted EPSper diluted share | £0.28 | £0.23 | £0.17 | £0.15 | £0.25 | £0.61 |